EDGAR Filing Documents for 0001193125-18-040424

Form 8-K - Current report:

SEC Accession No. 0001193125-18-040424

Filing Date

2018-02-13

Accepted

2018-02-12 17:32:59

Documents

Period of Report

2018-02-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d520750d8k.htm	8-K	40651
2	EX-1.1	d520750dex11.htm	EX-1.1	160632
3	EX-4.1	d520750dex41.htm	EX-4.1	109518
4	EX-4.3	d520750dex43.htm	EX-4.3	95059
5	EX-4.4	d520750dex44.htm	EX-4.4	95181
6	EX-5.1	d520750dex51.htm	EX-5.1	9223
7	EX-99.1	d520750dex991.htm	EX-99.1	14311
	Complete submission text file	0001193125-18-040424.txt		525924

Mailing Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476

Business Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476 612-747-4423

BioAmber Inc. (Filer) CIK: 0001534287 (see all company filings)